2022 annual financial data
PTC Therapeutics 2022 Net margin
Direct answer
Net margin was -80%.
Operating income was -447,409,000 USD and net income was -559,017,000 USD.
Operating cash flow was -356,654,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 698,801,000 USD
- Operating income
- -447,409,000 USD
- Net income
- -559,017,000 USD
- Operating cash flow
- -356,654,000 USD